Literature DB >> 15856429

The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.

Andreas Machens1, Hans-Jürgen Holzhausen, Henning Dralle.   

Abstract

BACKGROUND: A delay in the diagnosis of differentiated thyroid carcinoma often leads to larger tumors, higher prevalence rates of distant metastasis, and earlier cause-specific deaths. Threshold tumor diameters for extrathyroidal growth, lymph node spread, and distant metastasis in papillary (PTC) and follicular thyroid carcinoma (FTC) remain to be defined.
METHODS: A comparative correlation of primary tumor size and extrathyroidal growth, lymph node spread, and distant metastasis was performed for 500 institutional patients who received surgery for PTC or FTC.
RESULTS: There were 366 patients with PTC (73.2%) and 134 patients with FTC (26.8%). Multifocality (23.5% vs. 9.0%; P < 0.001) and lymph node metastasis (40.2% vs. 19.4%; P < 0.001) were more common in the patients with PTC than in those with FTC. Patients with FTC were older at first diagnosis (51.6 vs. 47.0 years; P = 0.01) compared with the patients with PTC. The FTC tumors were almost twice as large (39.9 vs. 20.6 mm; P < 0.001), and patients had a higher prevalence of distant metastasis (17.9% vs. 6.3%; P < 0.001). When primary tumor diameter was accounted for, cumulative risks of extrathyroidal growth and lymph node metastasis were higher in patients with PTC than in patients with FTC (P < 0.001; log-rank test). In striking contrast, the cumulative risk of distant metastasis was the same for PTC and FTC tumors of equal size (P = 0.89; log-rank test) and increased once the primary tumor size was > 20 mm. Pulmonary metastasis was an earlier event than bone metastasis.
CONCLUSIONS: The data suggested that earlier intervention is warranted to keep suspicious thyroid nodules from growing > 20 mm (or greater than T1) and spreading to distant organs.

Entities:  

Mesh:

Year:  2005        PMID: 15856429     DOI: 10.1002/cncr.21055

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  87 in total

1.  [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].

Authors:  M Stratmann; C Sekulla; H Dralle; M Brauckhoff
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

Review 2.  Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Authors:  Frederik A Verburg; Markus Dietlein; Michael Lassmann; Markus Luster; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Thyroid incidentaloma.

Authors:  Seema Singh; Anutosh Singh; A K Khanna
Journal:  Indian J Surg Oncol       Date:  2011-11-23

Review 4.  Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.

Authors:  Mark L Urken; Jeffery I Mechanick; Jonathan Sarlin; Sophie Scherl; Bruce M Wenig
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 5.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

6.  What should be done in thyroid nodules less than two centimeters, ultrasonographically suspicious and cytologically benign?

Authors:  Mevlüt Çahalov; Özer Makay; Gökhan İçöz; Mahir Akyıldız; Mustafa Yılmaz
Journal:  Ulus Cerrahi Derg       Date:  2013-12-01

7.  Decision analysis of discordant thyroid nodule biopsy guideline criteria.

Authors:  Christopher R McCartney; George J Stukenborg
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

8.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

Review 9.  Thyroid nodules and cancer management guidelines: comparisons and controversies.

Authors:  Fadi Nabhan; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2016-12-13       Impact factor: 5.678

10.  Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?

Authors:  Rosj Gallicchio; Sabrina Giacomobono; Daniela Capacchione; Anna Nardelli; Francesco Barbato; Antonio Nappi; Teresa Pellegrino; Giovanni Storto
Journal:  Endocrine       Date:  2013-03-28       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.